CN Stock MarketDetailed Quotes

605199 Hainan Huluwa Pharmaceutical Group

Watchlist
  • 10.16
  • +0.15+1.50%
Not Open Jul 11 15:00 CST
4.07BMarket Cap42.87P/E (TTM)

Hainan Huluwa Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-18.37%430.41M
25.75%1.91B
20.95%1.28B
24.61%913.98M
32.09%527.26M
11.91%1.52B
16.04%1.06B
16.20%733.46M
29.40%399.17M
16.53%1.35B
Operating revenue
-18.37%430.41M
25.75%1.91B
20.95%1.28B
24.61%913.98M
32.09%527.26M
11.91%1.52B
16.04%1.06B
16.20%733.46M
29.40%399.17M
16.53%1.35B
Other operating revenue
----
--0
----
--0
----
--0
----
--0
----
--0
Total operating cost
-13.72%402.98M
23.32%1.76B
20.33%1.18B
24.14%831.27M
30.40%467.07M
11.03%1.43B
16.74%982.04M
12.51%669.62M
27.62%358.18M
21.60%1.29B
Operating cost
-7.27%224.82M
40.91%899.83M
57.15%618.94M
64.24%436.65M
74.38%242.45M
17.15%638.58M
3.63%393.84M
-2.85%265.85M
4.85%139.03M
22.87%545.1M
Operating tax surcharges
-19.16%3.6M
23.08%16.84M
16.08%10.89M
21.18%8.38M
10.74%4.46M
-23.78%13.68M
-4.70%9.39M
-1.38%6.92M
44.87%4.03M
34.20%17.95M
Operating expense
-25.49%126.28M
9.23%638.21M
-1.64%416.14M
5.15%304.37M
7.04%169.48M
7.09%584.27M
23.19%423.1M
21.00%289.48M
37.58%158.33M
14.79%545.58M
Administration expense
-15.66%23.47M
37.89%96.3M
28.64%70.69M
18.99%44.27M
52.50%27.83M
3.69%69.84M
21.79%54.95M
23.02%37.21M
23.41%18.25M
1.65%67.35M
Financial expense
68.00%5.47M
1.46%17.21M
16.24%14.64M
-5.13%7.51M
-13.21%3.26M
60.44%16.96M
77.19%12.6M
89.19%7.91M
117.26%3.75M
29.55%10.57M
-Interest expense (Financial expense)
54.28%5.88M
1.33%18.24M
16.53%15.43M
-6.64%8.2M
-17.59%3.81M
29.77%18M
32.77%13.25M
57.92%8.78M
74.87%4.63M
52.35%13.87M
-Interest Income (Financial expense)
37.08%-453.78K
33.35%-1.34M
33.73%-1.06M
35.72%-923.92K
30.58%-721.25K
46.69%-2.01M
30.50%-1.6M
11.35%-1.44M
-6.46%-1.04M
-327.98%-3.77M
Research and development
-1.36%19.34M
-11.12%93.92M
-42.91%50.34M
-51.68%30.08M
-43.65%19.6M
5.21%105.66M
58.49%88.16M
52.54%62.25M
154.12%34.79M
94.40%100.43M
Credit Impairment Loss
89.86%-762.93K
-18,316.04%-22.95M
0.18%-7.75M
27.34%-6.52M
-55.47%-7.52M
103.90%125.97K
-122.74%-7.77M
-1,693.42%-8.98M
-98.28%-4.84M
68.26%-3.23M
Asset Impairment Loss
---313.67K
-39.03%-7.96M
---1.79M
---797.32K
----
-295.41%-5.73M
----
----
----
-99.87%-1.45M
Other net revenue
668.93%8.22M
-156.20%-5.94M
17.78%7.25M
9.06%4.26M
-71.77%-1.44M
4,287.95%10.57M
-65.01%6.15M
-81.29%3.9M
-156.72%-841.26K
-100.82%-252.37K
Invest income
201.14%2.52M
-115.32%-4.43M
-105.51%-4.46M
-542.79%-3.7M
-70,191.01%-2.49M
43.78%-2.06M
-19.22%-2.17M
62.95%-575.54K
98.18%-3.54K
-640.59%-3.66M
-Including: Investment income associates
550.76%2.52M
260.61%347.78K
-95.66%-1.17M
-18,902.99%-1.4M
---558.12K
--96.44K
---597.17K
---7.36K
----
----
Asset deal income
----
-628.71%-81.49K
---75.39K
---75.39K
---16.45K
87.63%-11.18K
----
----
----
54.84%-90.38K
Other revenue
-20.98%6.78M
61.64%29.48M
32.56%21.33M
14.09%15.35M
114.49%8.58M
122.95%18.24M
-30.01%16.09M
-38.44%13.46M
-2.84%4M
-80.74%8.18M
Operating profit
-39.32%35.64M
41.73%136.94M
28.33%103.59M
28.38%86.97M
46.31%58.74M
45.17%96.62M
-7.14%80.72M
18.99%67.74M
36.97%40.15M
-50.39%66.56M
Add:Non operating Income
25.15%570.81K
-72.09%738.07K
54.16%640.78K
226.77%497.76K
235.05%456.12K
-84.05%2.64M
324.66%415.65K
94.20%152.33K
1,641.56%136.14K
933.01%16.58M
Less:Non operating expense
-99.00%11.16K
7.00%2.18M
-0.61%1.41M
19.06%1.15M
18.63%1.12M
38.78%2.04M
26.18%1.42M
65.81%968.59K
91.98%941.63K
5.82%1.47M
Total profit
-37.67%36.2M
39.36%135.49M
28.98%102.81M
28.97%86.31M
47.63%58.08M
19.06%97.23M
-7.20%79.72M
18.61%66.92M
36.47%39.34M
-39.23%81.66M
Less:Income tax cost
-65.79%6.04M
83.20%22.87M
141.96%20M
139.66%23.13M
86.87%17.66M
3.12%12.49M
-15.81%8.27M
66.49%9.65M
83.70%9.45M
-6.04%12.11M
Net profit
-25.38%30.16M
32.90%112.62M
15.91%82.81M
10.32%63.18M
35.23%40.42M
21.83%84.74M
-6.09%71.45M
13.12%57.27M
26.21%29.89M
-42.75%69.56M
Net profit from continuing operation
-25.38%30.16M
32.90%112.62M
15.91%82.81M
10.32%63.18M
35.23%40.42M
21.83%84.74M
-6.09%71.45M
13.12%57.27M
26.21%29.89M
-42.75%69.56M
Less:Minority Profit
918.40%1.13M
751.23%6.12M
1,317.98%5.31M
617.70%1.82M
-526.68%-137.99K
63.58%-940.24K
65.93%-436.16K
72.65%-351.58K
-37.22%-22.02K
---2.58M
Net profit of parent company owners
-28.42%29.03M
24.29%106.5M
7.81%77.5M
6.49%61.36M
35.59%40.56M
18.78%85.68M
-7.08%71.89M
11.00%57.63M
26.22%29.91M
-40.63%72.14M
Earning per share
Basic earning per share
-30.00%0.07
28.57%0.27
5.56%0.19
7.14%0.15
42.86%0.1
16.67%0.21
-5.26%0.18
7.69%0.14
16.67%0.07
-43.75%0.18
Diluted earning per share
-30.00%0.07
28.57%0.27
5.56%0.19
7.14%0.15
42.86%0.1
16.67%0.21
-5.26%0.18
7.69%0.14
16.67%0.07
-43.75%0.18
Other composite income
Total composite income
-25.38%30.16M
32.90%112.62M
15.91%82.81M
10.32%63.18M
35.23%40.42M
21.83%84.74M
-6.09%71.45M
13.12%57.27M
26.21%29.89M
-42.75%69.56M
Total composite income of parent company owners
-28.42%29.03M
24.29%106.5M
7.81%77.5M
6.49%61.36M
35.59%40.56M
18.78%85.68M
-7.08%71.89M
11.00%57.63M
26.22%29.91M
-40.63%72.14M
Total composite income of minority owners
918.40%1.13M
751.23%6.12M
1,317.98%5.31M
617.70%1.82M
-526.68%-137.99K
63.58%-940.24K
65.93%-436.16K
72.65%-351.58K
-37.22%-22.02K
---2.58M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -18.37%430.41M25.75%1.91B20.95%1.28B24.61%913.98M32.09%527.26M11.91%1.52B16.04%1.06B16.20%733.46M29.40%399.17M16.53%1.35B
Operating revenue -18.37%430.41M25.75%1.91B20.95%1.28B24.61%913.98M32.09%527.26M11.91%1.52B16.04%1.06B16.20%733.46M29.40%399.17M16.53%1.35B
Other operating revenue ------0------0------0------0------0
Total operating cost -13.72%402.98M23.32%1.76B20.33%1.18B24.14%831.27M30.40%467.07M11.03%1.43B16.74%982.04M12.51%669.62M27.62%358.18M21.60%1.29B
Operating cost -7.27%224.82M40.91%899.83M57.15%618.94M64.24%436.65M74.38%242.45M17.15%638.58M3.63%393.84M-2.85%265.85M4.85%139.03M22.87%545.1M
Operating tax surcharges -19.16%3.6M23.08%16.84M16.08%10.89M21.18%8.38M10.74%4.46M-23.78%13.68M-4.70%9.39M-1.38%6.92M44.87%4.03M34.20%17.95M
Operating expense -25.49%126.28M9.23%638.21M-1.64%416.14M5.15%304.37M7.04%169.48M7.09%584.27M23.19%423.1M21.00%289.48M37.58%158.33M14.79%545.58M
Administration expense -15.66%23.47M37.89%96.3M28.64%70.69M18.99%44.27M52.50%27.83M3.69%69.84M21.79%54.95M23.02%37.21M23.41%18.25M1.65%67.35M
Financial expense 68.00%5.47M1.46%17.21M16.24%14.64M-5.13%7.51M-13.21%3.26M60.44%16.96M77.19%12.6M89.19%7.91M117.26%3.75M29.55%10.57M
-Interest expense (Financial expense) 54.28%5.88M1.33%18.24M16.53%15.43M-6.64%8.2M-17.59%3.81M29.77%18M32.77%13.25M57.92%8.78M74.87%4.63M52.35%13.87M
-Interest Income (Financial expense) 37.08%-453.78K33.35%-1.34M33.73%-1.06M35.72%-923.92K30.58%-721.25K46.69%-2.01M30.50%-1.6M11.35%-1.44M-6.46%-1.04M-327.98%-3.77M
Research and development -1.36%19.34M-11.12%93.92M-42.91%50.34M-51.68%30.08M-43.65%19.6M5.21%105.66M58.49%88.16M52.54%62.25M154.12%34.79M94.40%100.43M
Credit Impairment Loss 89.86%-762.93K-18,316.04%-22.95M0.18%-7.75M27.34%-6.52M-55.47%-7.52M103.90%125.97K-122.74%-7.77M-1,693.42%-8.98M-98.28%-4.84M68.26%-3.23M
Asset Impairment Loss ---313.67K-39.03%-7.96M---1.79M---797.32K-----295.41%-5.73M-------------99.87%-1.45M
Other net revenue 668.93%8.22M-156.20%-5.94M17.78%7.25M9.06%4.26M-71.77%-1.44M4,287.95%10.57M-65.01%6.15M-81.29%3.9M-156.72%-841.26K-100.82%-252.37K
Invest income 201.14%2.52M-115.32%-4.43M-105.51%-4.46M-542.79%-3.7M-70,191.01%-2.49M43.78%-2.06M-19.22%-2.17M62.95%-575.54K98.18%-3.54K-640.59%-3.66M
-Including: Investment income associates 550.76%2.52M260.61%347.78K-95.66%-1.17M-18,902.99%-1.4M---558.12K--96.44K---597.17K---7.36K--------
Asset deal income -----628.71%-81.49K---75.39K---75.39K---16.45K87.63%-11.18K------------54.84%-90.38K
Other revenue -20.98%6.78M61.64%29.48M32.56%21.33M14.09%15.35M114.49%8.58M122.95%18.24M-30.01%16.09M-38.44%13.46M-2.84%4M-80.74%8.18M
Operating profit -39.32%35.64M41.73%136.94M28.33%103.59M28.38%86.97M46.31%58.74M45.17%96.62M-7.14%80.72M18.99%67.74M36.97%40.15M-50.39%66.56M
Add:Non operating Income 25.15%570.81K-72.09%738.07K54.16%640.78K226.77%497.76K235.05%456.12K-84.05%2.64M324.66%415.65K94.20%152.33K1,641.56%136.14K933.01%16.58M
Less:Non operating expense -99.00%11.16K7.00%2.18M-0.61%1.41M19.06%1.15M18.63%1.12M38.78%2.04M26.18%1.42M65.81%968.59K91.98%941.63K5.82%1.47M
Total profit -37.67%36.2M39.36%135.49M28.98%102.81M28.97%86.31M47.63%58.08M19.06%97.23M-7.20%79.72M18.61%66.92M36.47%39.34M-39.23%81.66M
Less:Income tax cost -65.79%6.04M83.20%22.87M141.96%20M139.66%23.13M86.87%17.66M3.12%12.49M-15.81%8.27M66.49%9.65M83.70%9.45M-6.04%12.11M
Net profit -25.38%30.16M32.90%112.62M15.91%82.81M10.32%63.18M35.23%40.42M21.83%84.74M-6.09%71.45M13.12%57.27M26.21%29.89M-42.75%69.56M
Net profit from continuing operation -25.38%30.16M32.90%112.62M15.91%82.81M10.32%63.18M35.23%40.42M21.83%84.74M-6.09%71.45M13.12%57.27M26.21%29.89M-42.75%69.56M
Less:Minority Profit 918.40%1.13M751.23%6.12M1,317.98%5.31M617.70%1.82M-526.68%-137.99K63.58%-940.24K65.93%-436.16K72.65%-351.58K-37.22%-22.02K---2.58M
Net profit of parent company owners -28.42%29.03M24.29%106.5M7.81%77.5M6.49%61.36M35.59%40.56M18.78%85.68M-7.08%71.89M11.00%57.63M26.22%29.91M-40.63%72.14M
Earning per share
Basic earning per share -30.00%0.0728.57%0.275.56%0.197.14%0.1542.86%0.116.67%0.21-5.26%0.187.69%0.1416.67%0.07-43.75%0.18
Diluted earning per share -30.00%0.0728.57%0.275.56%0.197.14%0.1542.86%0.116.67%0.21-5.26%0.187.69%0.1416.67%0.07-43.75%0.18
Other composite income
Total composite income -25.38%30.16M32.90%112.62M15.91%82.81M10.32%63.18M35.23%40.42M21.83%84.74M-6.09%71.45M13.12%57.27M26.21%29.89M-42.75%69.56M
Total composite income of parent company owners -28.42%29.03M24.29%106.5M7.81%77.5M6.49%61.36M35.59%40.56M18.78%85.68M-7.08%71.89M11.00%57.63M26.22%29.91M-40.63%72.14M
Total composite income of minority owners 918.40%1.13M751.23%6.12M1,317.98%5.31M617.70%1.82M-526.68%-137.99K63.58%-940.24K65.93%-436.16K72.65%-351.58K-37.22%-22.02K---2.58M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg